You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Salamina A, Giglioni C, Noferi V, et al
2022-RA-1662-ESGO Tumor induced stromal senescence in high grade serious ovarian cancer. A preclinical study on novel prognostic biomarkers and preliminary prospects on therapeutic potential
International Journal of Gynecologic Cancer 2022;32:A359.